BioCardia, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCDA research report →
About the company
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia.
- CEO
- Peter A. Altman
- IPO
- 1996
- Employees
- 17
- HQ
- Sunnyvale, CA, US
Price Chart
- Market Cap
- $6.96M
- P/E
- -1.67
- P/S
- 0.00
- P/B
- -12.17
- EV/EBITDA
- -0.87
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -5456.14%
- ROIC
- 1195.41%
- Revenue
- $0 · -100.00%
- Net Income
- $-8,228,000 · -3.55%
- EPS
- $-1.23 · 57.59%
- Op Income
- $-8,278,000
- FCF YoY
- 7.33%
- 52W High
- $2.45
- 52W Low
- $0.78
- 50D MA
- $1.02
- 200D MA
- $1.23
- Beta
- 0.50
- Avg Volume
- 3.05M
Get TickerSpark's AI analysis on BCDA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Altman Peter | other | 110,625 |
| Jun 29, 26 | McClung David | other | 60,483 |
| Jun 29, 26 | GILLIS EDWARD M | other | 39,521 |
| Jun 23, 26 | STERTZER SIMON H | buy | 39,000 |
| Jun 22, 26 | STERTZER SIMON H | buy | 70,200 |
| Jun 18, 26 | Altman Peter | buy | 800 |
| Jun 17, 26 | Altman Peter | buy | 1,500 |
| Jun 9, 26 | Altman Peter | buy | 5,000 |
| May 20, 26 | Altman Peter | buy | 1,500 |
| May 19, 26 | Altman Peter | buy | 200 |
Our BCDA coverage
Recent articles, reports, and earnings notes.
No research on BCDA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCDA report →Similar companies
Peers in the same neighborhood.